{"entity":{"id":"paper-de-visser-cancer-cell","kind":"paper","name":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","aka":[],"tldr":"Paper cited by one pathway page, indexed on Europe PMC as PubMed record 36917948 and published in Cancer Cell; the citing page links this DOI, which is how the record was matched.","summary":"Cancers represent complex ecosystems comprising tumor cells and a multitude of non-cancerous cells, embedded in an altered extracellular matrix. The tumor microenvironment (TME) includes diverse immune cell types, cancer-associated fibroblasts, endothelial cells, pericytes, and various additional tissue-resident cell types. These host cells were once considered bystanders of tumorigenesis but are now known to play critical roles in the pathogenesis of cancer. The cellular composition and functional state of the TME can differ extensively depending on the organ in which the tumor arises, the intrinsic features of cancer cells, the tumor stage, and patient characteristics. Here, we review the importance of the TME in each stage of cancer progression, from tumor initiation, progression, invasion, and intravasation to metastatic dissemination and outgrowth. Understanding the complex interplay between tumor cell-intrinsic, cell-extrinsic, and systemic mediators of disease progression is critical for the rational development of effective anti-cancer treatments.\n\nIndexed on Europe PMC as PubMed record 36917948 (DOI 10.1016/j.ccell.2023.02.016). Matched by DOI alone: one pathway page cites this DOI among its external links (the pages are listed under Related), and this page was written so that the citation resolves inside OnCo. No figure has been checked by an editor.","asOf":"2026-09-22","links":[{"label":"Cancer Cell 2023","url":"https://doi.org/10.1016/j.ccell.2023.02.016"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/36917948/"},{"label":"Europe PMC","url":"https://europepmc.org/article/MED/36917948"}],"tags":["europepmc-ingest"],"related":["tumor-microenvironment"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["cancer-cell"],"dependsOn":[],"notes":[],"journal":"Cancer Cell","year":2023,"doi":"10.1016/j.ccell.2023.02.016","pmid":"36917948","authors":"de Visser KE, Joyce JA","paperType":"review","findings":[],"whatItMeans":"One pathway page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.","caveats":["Matched to the citing OnCo records by DOI alone; the summary reproduces the Europe PMC abstract and no figure has been verified against the full paper."]},"route":"/key-papers/paper-de-visser-cancer-cell/","neighbours":{"pathway":[{"id":"tumor-microenvironment","kind":"pathway","name":"Tumour microenvironment (TME)","route":"/pathways/tumor-microenvironment/"}],"journal":[{"id":"cancer-cell","kind":"journal","name":"Cancer Cell","route":"/journals/cancer-cell/"}]}}